In many studies, expression of phenotypic markers such as the cell surface glycoproteins CD133 and CD44 has been used to separate TICs from the bulk of tumor cells that lack tumor regenerative activity (Al‐Hajj et al, 2003; Ricci‐Vitiani et al, 2007). This evidence concerns the gene CD44 and neoplasm.